Home : Unsafe Drugs : Zetia : News Articles
Zetia - News Articles
-
May 21, 2008
Corante, MA -
There’s ezetimibe, discovered by sheer chance (but developed by sheer determination, though) and the thrombin receptor antagonist, squirrelly chemical ... -
May 13, 2008
Corante, MA -
Vytorin (ezetimibe) is the example I’ve spoken about here, and if the drug doesn’t seem like a savior at the moment, well, you have to keep in mind that it was the biggest thing for them since Claritin went off-patent ten years ago. Now there’s another one ... -
Jan 14, 2008
Wall Street Journal -
The study -- known as Enhance, or Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients ... -
Jan 16, 2008
Medical News Today, UK -
ENHANCE stands for Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia. The ACC said the study deserves "serious thought and follow-up". The overall rate of ... -
Jan 16, 2008
DG News -
DALLAS, TX -- January 16, 2008 -- Merck/Schering-Plough Pharmaceuticals released results from the ENHANCE trial, which found that the ezetimibe/simvastatin (Zetia/Zocor) combination drug known as Vytorin was no more effective in reducing artery plaque build-up than simvastatin (Zocor) alone. ... -
Jan 17, 2008
Earthtimes, UK -
JACKSONVILLE, Fla., Jan. 17 -- The limitations of the ENHANCE study, in terms of its design and the patients studied, are such that physicians should not alter their prescribing policies at this time. Current discussion regarding the ENHANCE Study is not based upon published work ... -
Jan 14, 2008
TheHeart.Org, NY -
At baseline, the mean carotid IMT measurement for the ezetimibe/simvastatin group was 0.68 mm and for the simvastatin-80-mg group was 0.69 mm. ... -
Jan 16, 2008
TheHeart.Org, NY -
It was the lead item on many US television news programs on Monday, and sales of ezetimibe—which have been running at around $5 billion worldwide—are now ... -
Thursday, January 17, 2008
Health24.com, South Africa -
Researchers reported this week that the widely prescribed cholesterol-lowering drug Ezetimibe (Zetia) does not confer any medical benefit. ... -
Jan 14, 2008
MedPage Today, NJ -
14 -- The combination of ezetimibe/simvastatin (Vytorin) did not appear to slow progression of atherosclerosis among patients with heterozygous familial hypercholesterolemia, doesn't that imply that genetically they are producing too much cholesterol ?If that is true, then it is ...
-
Jan 16, 2008
MedPage Today, NJ -
By Peggy Peck, Executive Editor, MedPage Today DALLAS, Jan. 16 -- A shortage of people trained in CPR contributes to the approximately 150000 ... -
Jan 16, 2008
MedPage Today, NJ -
By Peggy Peck, Executive Editor, MedPage Today WASHINGTON, Jan. 16 -- Both the American College of Cardiology and the American Heart Association have warned against a rush to judgment on ezetimibe/simvastatin (Vytorin) on the basis of the scant details of the ENHANCE study ... -
Jan 15, 2008
About.com - Drugs, NY -
A new trial of 720 patients showed that adding Zetia (ezetimibe) to Zocor (simvastatin) provides no benefit for reducing atherosclerotic plaques. ... -
Jan 15, 2008
13abc.com, OH -
About one million new presciptions for Zetia are written each week, and it is a big seller for Merck and Schering Plough, the drug companies which combine Zetia to make the drug Zocor. Now a new study raises questions about Zetia's effectiveness. ... -
Jan 15, 2008
SeniorJournal.com, TX -
15, 2008 – The bottom line for cholesterol-fighting senior citizens is that Zetia does not work in reducing your heart disease risk. It does not reduce your risk of clogged arteries as a part of Vytorin, either. ... -
Jan 16, 2008
phillyBurbs.com, PA -
While I certainly don’t like the price - about $40-50 per month out of my own pocket in adddition to what insurance pays - it’s hard to argue that Vytorin isn’t effective. In just two months of being on a higher dosage of the stuff, after years ... -
Jan 15, 2008
CBS 21, PA -
The word is out about the cholesterol reducing drug Zetia. A recent study shows it may not have the effectiveness that the medical community first thought. CBS 21 News spoke with a local cardiologist who says we're yet to hear the final word on the ... -
Jan 16, 2008
phillyBurbs.com, PA -
A lifelong Philly sports fan, I've been proudly breaking the Internet since 1999 when I first became an online editor. In my first life, I was an award-winning investigative reporter - a different kind of hired geek - for 12 years. ... -
Jan 16, 2008
ABC News -
A congressional subcommittee is investigating celebrity endorsements in direct-to-consumer drug ads, including Lipitor's ads featuring Robert Jarvik, inventor of the artificial heart. (ABC News Photo Illustration) ... -
Jan 16, 2008
Atlanta Journal Constitution, USA -
Twenty-five years ago, young Robert Jarvik was a physician-inventor best known for a plastic-and-titanium artificial heart that seemed to work for a while but had a nasty habit of causing strokes. Now he's the frontman for a multi-million-dollar advertising campaign for the ...
Pages: 1 2 3 4 5 6 ... Next






